Why is Remedium Life falling/rising?

As of 04-Sep, Remedium Lifecare Ltd's stock price is currently at 1.32, reflecting an increase of 0.04 or 3.13%. The stock has shown a positive trend today, outperforming its sector by 2.73% and reversing a two-day decline. Over the past week, the stock has gained 5.60%, while its one-month performance is up by 2.33%. However, the company faces significant challenges, including a high Debt to EBITDA ratio of -1.00 times and a negative return on capital employed (ROCE), indicating a low ability to service debt. The company has reported losses for the last four consecutive quarters, with net sales falling by 76.36%, which has contributed to a very negative outlook.
In the broader market context, the stock's recent performance contrasts sharply with the benchmark, as it has underperformed significantly over the past year with a return of -80.16%, compared to the Sensex's decline of only -1.98%. Despite the stock's short-term gains, the long-term growth prospects appear poor, with an annual operating profit decline of -303.30% over the last five years. This combination of short-term positive movement and long-term negative indicators suggests that while there may be temporary gains, the overall sentiment remains cautious due to the company's financial instability and poor growth trajectory.